Developing a Strategy for Re-Administration of AAV Gene Therapies
Time: 3:15 pm
day: Day Two
Details:
- Discuss the concerns surrounding immune responses to AAV vectors
- Outline the importance of shifting away from a ‘one-and-done’ approach
- How to develop a successful strategy to enable re-administration of gene therapies
